- Investing Ideas
- /
- Mexican Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Mexican Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
1
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LAB B New | Mex$27.49 | -2.9% | 105.8% | Mex$26.1b | Mex$27.80 | PE15.9x | E19.5% | 2.9% |
Page 1 of 1